Have a specific question about your LBP project? Click below and let’s get started.
Journal of Experimental Medicine
Yoon, J;Leyva-Castillo, JM;Wang, G;Galand, C;Oyoshi, MK;Kumar, L;Hoff, S;He, R;Chervonsky, A;Oppenheim, JJ;Kuchroo, VK;van den Brink, MR;Malefyt, RW;Tessier, PA;Fuhlbrigge, R;Rosenstiel, P;Terhorst, C;Murphy, G;Geha, RS;
Atopic dermatitis (AD) is a Th2-dominated inflammatory skin disease characterized by epidermal thickening. Serum levels of IL-22, a cytokine known to induce keratinocyte proliferation, are elevated in AD, and Th22 cells infiltrate AD skin lesions. We show that application of antigen to mouse skin subjected to tape stripping, a surrogate for scratching, induces an IL-22 response that drives epidermal hyperplasia and keratinocyte proliferation in a mouse model of skin inflammation that shares many features of AD. DC-derived IL-23 is known to act on CD4(+) T cells to induce IL-22 production. However, the mechanisms that drive IL-23 production by skin DCs in response to cutaneous sensitization are not well understood. We demonstrate that IL-23 released by keratinocytes in response to endogenous TLR4 ligands causes skin DCs, which selectively express IL-23R, to up-regulate their endogenous IL-23 production and drive an IL-22 response in naive CD4(+) T cells that mediates epidermal thickening. We also show that IL-23 is released in human skin after scratching and polarizes human skin DCs to drive an IL-22 response, supporting the utility of IL-23 and IL-22 blockade in AD.